Abingworth LLP
CIK
1397144
Location
LONDON, X0
Portfolio Value
Small
$172,575,122
Diversification
Highly concentrated
Filing Date
Global Rank
#3,314
/ 6,944
▼ 167
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-0.6%
Period ended 3 years ago
Filed Feb 10, 2023 · 3y
12 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+73.7%
SPY
+76.5%
Annualised alpha
-0.6%
Max drawdown
−63.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
4 positions · as of Dec 31, 2022 · Δ vs Sep 30, 2022Top Position
56.1%
+0.8 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
4,338
Highly concentrated−9
Portfolio Trend
12 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2022| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $172,575,122 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | −2,149,661 | 2,019,057 | $96,813,783 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
4 positions ·
$172,575,122 total
· as of Dec 31, 2022
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 2,019,057 | $96,813,783 | 56.10% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 2,960,231 | $57,280,469 | 33.19% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Held | 1,435,106 | $16,101,889 | 9.33% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Held | 1,201,506 | $2,378,981 | 1.38% |